Part D plans generally include drugs commonly used by dual-eligible enrollees: 2023

Part D plans generally include drugs commonly used by dual-eligible enrollees: 2023

Collection:
Health Policy and Services Research
Series Title(s):
Data snapshot (United States. Department of Health and Human Services. Office of Inspector General)
Contributor(s):
United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections, issuing body.
Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023
Language(s):
English
Format:
Text
Subject(s):
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Government Regulation
Medicare Part D
Prescription Drugs
United States
Genre(s):
Technical Report
Abstract:
Why OIG Did This Review. For dual-eligible enrollees - that is, people enrolled in both Medicare and Medicaid - access to prescription drugs is particularly important. Overall, they have very low incomes and - because they are more likely to be in poorer health than other people enrolled in Medicare - tend to use more Medicare services. Because Medicare prescription drug coverage is an important tool for ensuring access to prescription drugs, Congress mandated that OIG study whether Part D formularies cover prescription drugs commonly used by dual-eligible enrollees. What OIG Did. For this report, we determined whether the 445 unique formularies used by the 5,619 Part D plans operating in 2023 cover 195 of the 200 drugs most commonly used by dual-eligible enrollees. See the methodology for more information about how we determined the most commonly used drugs. This is OIG’s thirteenth annually mandated report examining dual-eligible enrollees’ access to drugs under Medicare Part D.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)
Extent:
1 online resource (1 PDF file (6 pages))
Illustrations:
Illustrations
NLM Unique ID:
9918716087906676 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/9918716087906676